Literature DB >> 16280357

Regulation of histone deacetylase 4 expression by the SP family of transcription factors.

Fang Liu1, Nabendu Pore, Mijin Kim, K Ranh Voong, Melissa Dowling, Amit Maity, Gary D Kao.   

Abstract

Histone deacetylases mediate critical cellular functions but relatively little is known about mechanisms controlling their expression, including expression of HDAC4, a class II HDAC implicated in the modulation of cellular differentiation and viability. Endogenous HDAC4 mRNA, protein levels and promoter activity were all readily repressed by mithramycin, suggesting regulation by GC-rich DNA sequences. We validated consensus binding sites for Sp1/Sp3 transcription factors in the HDAC4 promoter through truncation studies and targeted mutagenesis. Specific and functional binding by Sp1/Sp3 at these sites was confirmed with chromatin immunoprecipitation (ChIP) and electromobility shift assays (EMSA). Cotransfection of either Sp1 or Sp3 with a reporter driven by the HDAC4 promoter led to high activities in SL2 insect cells (which lack endogenous Sp1/Sp3). In human cells, restored expression of Sp1 and Sp3 up-regulated HDAC4 protein levels, whereas levels were decreased by RNA-interference-mediated knockdown of either protein. Finally, variable levels of Sp1 were in concordance with that of HDAC4 in a number of human tissues and cancer cell lines. These studies together characterize for the first time the activity of the HDAC4 promoter, through which Sp1 and Sp3 modulates expression of HDAC4 and which may contribute to tissue or cell-line-specific expression of HDAC4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280357      PMCID: PMC1356571          DOI: 10.1091/mbc.e05-08-0775

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  85 in total

Review 1.  Sp1: regulation of gene expression by phosphorylation.

Authors:  Shijian Chu; Thomas J Ferro
Journal:  Gene       Date:  2005-03-28       Impact factor: 3.688

Review 2.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Sp1 and Sp3 activate transcription of the human dopamine transporter gene.

Authors:  Jun Wang; Michael J Bannon
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

4.  Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.

Authors:  George Koutsodontis; Eleftheria Vasilaki; Wan-Chih Chou; Paraskevi Papakosta; Dimitris Kardassis
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

5.  Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats.

Authors:  S H Lecker; V Solomon; S R Price; Y T Kwon; W E Mitch; A L Goldberg
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.

Authors:  Toshitaka Shin; Hideaki Sumiyoshi; Noritaka Matsuo; Fuminori Satoh; Yoshio Nomura; Hiromitsu Mimata; Hidekatsu Yoshioka
Journal:  Arch Biochem Biophys       Date:  2005-03-15       Impact factor: 4.013

7.  ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line.

Authors:  Rana Varshochi; Faezah Halim; Andrew Sunters; John P Alao; Patricia A Madureira; Stephen M Hart; Simak Ali; David M Vigushin; R Charles Coombes; Eric W-F Lam
Journal:  J Biol Chem       Date:  2004-11-19       Impact factor: 5.157

8.  Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.

Authors:  Weiqi Huang; Shujie Zhao; Sudhakar Ammanamanchi; Michael Brattain; Kolaparthi Venkatasubbarao; James W Freeman
Journal:  J Biol Chem       Date:  2005-01-12       Impact factor: 5.157

9.  Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.

Authors:  Serge Grégoire; Xiang-Jiao Yang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  The expression of the human neuronal alpha3 Na+,K+-ATPase subunit gene is regulated by the activity of the Sp1 and NF-Y transcription factors.

Authors:  Roberta Benfante; Ruth Adele Antonini; Monica Vaccari; Adriano Flora; Fabian Chen; Francesco Clementi; Diego Fornasari
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

View more
  23 in total

1.  Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies.

Authors:  Christoph Bachmann; Faiza Noreen; Nicol C Voermans; Primo L Schär; John Vissing; Johanna M Fock; Saskia Bulk; Benno Kusters; Steven A Moore; Alan H Beggs; Katherine D Mathews; Megan Meyer; Casie A Genetti; Giovanni Meola; Rosanna Cardani; Emma Mathews; Heinz Jungbluth; Francesco Muntoni; Francesco Zorzato; Susan Treves
Journal:  Hum Mutat       Date:  2019-04-01       Impact factor: 4.878

2.  Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.

Authors:  Chun-Han Chen; Po-Hsien Huang; Po-Chen Chu; Mei-Chuan Chen; Chih-Chien Chou; Dasheng Wang; Samuel K Kulp; Che-Ming Teng; Qianben Wang; Ching-Shih Chen
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

3.  Mithramycin A suppresses expression of the human melanoma-associated gene ABCB8.

Authors:  Iwona Sachrajda; Marcin Ratajewski
Journal:  Mol Genet Genomics       Date:  2010-11-03       Impact factor: 3.291

4.  Sp1-dependent activation of HDAC7 is required for platelet-derived growth factor-BB-induced smooth muscle cell differentiation from stem cells.

Authors:  Li Zhang; Min Jin; Andriana Margariti; Gang Wang; Zhenling Luo; Anna Zampetaki; Lingfang Zeng; Shu Ye; Jianhua Zhu; Qingzhong Xiao
Journal:  J Biol Chem       Date:  2010-10-01       Impact factor: 5.157

5.  MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation.

Authors:  Eros Di Giorgio; Andrea Clocchiatti; Sara Piccinin; Andrea Sgorbissa; Giulia Viviani; Paolo Peruzzo; Salvatore Romeo; Sabrina Rossi; Angelo Paolo Dei Tos; Roberta Maestro; Claudio Brancolini
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

Review 6.  HDAC4: mechanism of regulation and biological functions.

Authors:  Zhengke Wang; Gangjian Qin; Ting C Zhao
Journal:  Epigenomics       Date:  2014-02       Impact factor: 4.778

7.  HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression.

Authors:  Emi Shimizu; Nagarajan Selvamurugan; Jennifer J Westendorf; Eric N Olson; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

8.  A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression.

Authors:  Huibin Tang; Peter Macpherson; Michael Marvin; Eric Meadows; William H Klein; Xiang-Jiao Yang; Daniel Goldman
Journal:  Mol Biol Cell       Date:  2008-12-24       Impact factor: 4.138

9.  HDAC4 promotes growth of colon cancer cells via repression of p21.

Authors:  Andrew J Wilson; Do-Sun Byun; Shannon Nasser; Lucas B Murray; Kanyalakshmi Ayyanar; Diego Arango; Maria Figueroa; Ari Melnick; Gary D Kao; Leonard H Augenlicht; John M Mariadason
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

10.  Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.

Authors:  Bérengère Vire; Stéphane de Walque; Audrey Restouin; Daniel Olive; Carine Van Lint; Yves Collette
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.